FDA stresses birth defect risks with Roche drug
May 16th, 2008 By MATTHEW PERRONE, AP Business Writer(AP) -- Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Epilepsy drug may increase risk of birth defects
Jul 21, 2008 |
not rated yet |
0
Miscarriage and infertility treatment increase pre-eclampsia risk
Dec 18, 2008 |
not rated yet |
0
FDA issues Myfortic tablets safety alert
Nov 28, 2007 |
not rated yet |
0
New insights into thalidomide-birth defect episode
Nov 10, 2008 |
3.3 / 5 (3) |
0
Epilepsy drug may increase risk of autism in children
Dec 01, 2008 |
4.5 / 5 (2) |
3

